301 related articles for article (PubMed ID: 2704078)
1. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
Feuer G; Taketo M; Hanecak RC; Fan H
J Virol; 1989 May; 63(5):2317-24. PubMed ID: 2704078
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the binding proteins and activity of the long terminal repeat of Moloney murine leukemia virus during differentiation of mouse embryonal carcinoma cells.
Tsukiyama T; Niwa O; Yokoro K
J Virol; 1991 Jun; 65(6):2979-86. PubMed ID: 2033663
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells.
Tsukiyama T; Niwa O; Yokoro K
Mol Cell Biol; 1989 Nov; 9(11):4670-6. PubMed ID: 2601693
[TBL] [Abstract][Full Text] [Related]
4. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Feuer G; Fan H
J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
[TBL] [Abstract][Full Text] [Related]
5. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
Ch'ang LY; Yang WK; Myer FE; Yang DM
J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
[TBL] [Abstract][Full Text] [Related]
6. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
7. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
Fan H; Chute H; Chao E; Pattengale PK
Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
[TBL] [Abstract][Full Text] [Related]
8. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
Overhauser J; Fan H
J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
[TBL] [Abstract][Full Text] [Related]
9. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells.
Challita PM; Skelton D; el-Khoueiry A; Yu XJ; Weinberg K; Kohn DB
J Virol; 1995 Feb; 69(2):748-55. PubMed ID: 7815539
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation.
Wang XY; McCubrey JA
Leukemia; 1997 Oct; 11(10):1711-25. PubMed ID: 9324293
[TBL] [Abstract][Full Text] [Related]
11. Derivatives of Moloney murine sarcoma virus capable of being transcribed in embryonal carcinoma stem cells have gained a functional Sp1 binding site.
Prince VE; Rigby PW
J Virol; 1991 Apr; 65(4):1803-11. PubMed ID: 1848307
[TBL] [Abstract][Full Text] [Related]
12. Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells.
Loh TP; Sievert LL; Scott RW
Mol Cell Biol; 1987 Oct; 7(10):3775-84. PubMed ID: 3683398
[TBL] [Abstract][Full Text] [Related]
13. Chromatin structure of recombinant Moloney murine leukemia virus proviral DNAs that contain tax-responsive sequences from human T-cell lymphotropic virus type II in the presence and absence of tax.
Kitado H; Fan H
J Virol; 1989 Jul; 63(7):3072-9. PubMed ID: 2786092
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the negative regulatory element of the 5' noncoding region of Moloney murine leukemia virus in mouse embryonal carcinoma cells.
Tsukiyama T; Niwa O; Yokoro K
Virology; 1990 Aug; 177(2):772-6. PubMed ID: 2371781
[TBL] [Abstract][Full Text] [Related]
15. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
16. Mapping of DNase I-hypersensitive sites in the 5' and 3' long terminal repeats of integrated moloney murine leukemia virus proviral DNA.
Thompson T; Fan H
Mol Cell Biol; 1985 Apr; 5(4):601-9. PubMed ID: 2985961
[TBL] [Abstract][Full Text] [Related]
17. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
Granger SW; Fan H
J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
[TBL] [Abstract][Full Text] [Related]
18. A cellular enhancer of retrovirus gene expression in embryonal carcinoma cells.
Taketo M; Tanaka M
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3748-52. PubMed ID: 3473480
[TBL] [Abstract][Full Text] [Related]
19. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector gene expression in F9 embryonal carcinoma cells.
Linney E; Neill SD; Prestridge DS
J Virol; 1987 Oct; 61(10):3248-53. PubMed ID: 3041045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
